Terms: = Kidney tumors AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Prognosis
15 results:
1. Analysis of clinical characteristics and prognostic factors of elderly patients with renal cell carcinoma based on the SEER database.
Peng X; Sun H; Wang L; Guo W; Zhao Z; Yang J
Medicine (Baltimore); 2023 Jun; 102(25):e34069. PubMed ID: 37352082
[TBL] [Abstract] [Full Text] [Related]
2. The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk.
Yang Y; Zhang G; Hu C; Luo W; Jiang H; Liu S; Yang H
BMC Urol; 2022 Nov; 22(1):196. PubMed ID: 36451132
[TBL] [Abstract] [Full Text] [Related]
3. A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study.
Hu Y; Xu S; Qi Q; Wang X; Meng J; Zhou J; Hao Z; Liang Q; Feng X; Liang C
Front Public Health; 2022; 10():989566. PubMed ID: 36276376
[TBL] [Abstract] [Full Text] [Related]
4. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract] [Full Text] [Related]
5. Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma.
Meng H; Jiang X; Cui J; Yin G; Shi B; Liu Q; Xuan H; Wang Y
Biomed Res Int; 2020; 2020():2495157. PubMed ID: 33062672
[TBL] [Abstract] [Full Text] [Related]
6. Ancestry-specific predisposing germline variants in cancer.
Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive analysis of long non‑coding RNA using an associated competitive endogenous RNA network in Wilms tumor.
Wang Z; Cheng H; Qi L; Sui D
Mol Med Rep; 2020 Jul; 22(1):105-116. PubMed ID: 32377711
[TBL] [Abstract] [Full Text] [Related]
8. Differential expression analysis of clear cell renal cell carcinomas in The Cancer Genome Atlas distinguishes an aggressive subset enriched with chromosomes 7 and 12 gains.
Pan CC; Yeh YC; Wang YC; Chang YH
Histopathology; 2020 Jun; 76(7):950-958. PubMed ID: 32170764
[TBL] [Abstract] [Full Text] [Related]
9. Development and verification of a nomogram for prediction of recurrence-free survival in clear cell renal cell carcinoma.
Chen Y; Jiang S; Lu Z; Xue D; Xia L; Lu J; Wang H; Xu L; Li L; Li G
J Cell Mol Med; 2020 Jan; 24(2):1245-1255. PubMed ID: 31782902
[TBL] [Abstract] [Full Text] [Related]
10. Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas.
Shafiei S; Kalantari E; Saeednejad Zanjani L; Abolhasani M; Asadi Lari MH; Madjd Z
Exp Mol Pathol; 2019 Jun; 108():164-172. PubMed ID: 31028726
[TBL] [Abstract] [Full Text] [Related]
11. Low Expression of atm Indicates a Poor prognosis in Clear Cell Renal Cell Carcinoma.
Ren W; Xue B; Chen M; Liu L; Zu X
Clin Genitourin Cancer; 2019 Jun; 17(3):e433-e439. PubMed ID: 30773312
[TBL] [Abstract] [Full Text] [Related]
12. p53β: a new prognostic marker for patients with clear-cell renal cell carcinoma from 5.3 years of median follow-up.
Zhang H; Zhao Y; Sun P; Zhao M; Su Z; Jin X; Song W
Carcinogenesis; 2018 Mar; 39(3):368-374. PubMed ID: 29346503
[TBL] [Abstract] [Full Text] [Related]
13. Metallothionein - immunohistochemical cancer biomarker: a meta-analysis.
Gumulec J; Raudenska M; Adam V; Kizek R; Masarik M
PLoS One; 2014; 9(1):e85346. PubMed ID: 24416395
[TBL] [Abstract] [Full Text] [Related]
14. Management of renal cell carcinoma with tumor thrombus in renal vein and the inferior vena cava.
Qi J; Gu Z; Chen F; Shen H; Chen J; Zhang L; Wang W
Ann Vasc Surg; 2010 Nov; 24(8):1089-93. PubMed ID: 20471214
[TBL] [Abstract] [Full Text] [Related]
15. Solid tumors of childhood.
Sharma S; Mishra K; Agarwal S; Khanna G
Indian J Pediatr; 2004 Jun; 71(6):501-4. PubMed ID: 15226558
[TBL] [Abstract] [Full Text] [Related]
